EPRX
Price
$5.49
Change
-$0.05 (-0.90%)
Updated
Jul 25 closing price
Capitalization
198.96M
12 days until earnings call
IVEVF
Price
$2.28
Change
-$1.36 (-37.36%)
Updated
Feb 12 closing price
Capitalization
448.66M
Interact to see
Advertisement

EPRX vs IVEVF

Header iconEPRX vs IVEVF Comparison
Open Charts EPRX vs IVEVFBanner chart's image
Eupraxia Pharmaceuticals
Price$5.49
Change-$0.05 (-0.90%)
Volume$32.12K
Capitalization198.96M
INVENTIVA SA
Price$2.28
Change-$1.36 (-37.36%)
Volume$1K
Capitalization448.66M
EPRX vs IVEVF Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. IVEVF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and IVEVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EPRX: $5.49 vs. IVEVF: $2.28)
Brand notoriety: EPRX and IVEVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 248% vs. IVEVF: 100%
Market capitalization -- EPRX: $198.96M vs. IVEVF: $448.66M
EPRX [@Biotechnology] is valued at $198.96M. IVEVF’s [@Biotechnology] market capitalization is $448.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileIVEVF’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • IVEVF’s FA Score: 0 green, 5 red.
According to our system of comparison, both EPRX and IVEVF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • EPRX’s TA Score: 4 bullish, 4 bearish.

Price Growth

EPRX (@Biotechnology) experienced а +3.82% price change this week, while IVEVF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVEVF($449M) has a higher market cap than EPRX($199M). EPRX YTD gains are higher at: 73.186 vs. IVEVF (-37.363).
EPRXIVEVFEPRX / IVEVF
Capitalization199M449M44%
EBITDA-25.89MN/A-
Gain YTD73.186-37.363-196%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash27.5MN/A-
Total Debt52.8KN/A-
TECHNICAL ANALYSIS
Technical Analysis
EPRXIVEVF
RSI
ODDS (%)
Bearish Trend 3 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
42%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
13%
Advances
ODDS (%)
Bullish Trend 20 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
70%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUMIF0.03N/A
+14.58%
Numinus Wellness Inc.
RCIAF30.03N/A
N/A
Rogers Communications, Inc.
BGPBF23.35N/A
N/A
BTS Group AB
PRPS0.60N/A
N/A
PROPELLUS INC.
VLOWY3.86-0.10
-2.53%
Vallourec SA

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and IVEVF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-0.90%
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
+0.87%
PHMMF - EPRX
25%
Poorly correlated
N/A
ALEC - EPRX
25%
Poorly correlated
-1.68%
IMUX - EPRX
24%
Poorly correlated
N/A
More

IVEVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with TRDA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVEVF
1D Price
Change %
IVEVF100%
N/A
TRDA - IVEVF
47%
Loosely correlated
+2.35%
MBCOF - IVEVF
32%
Poorly correlated
+1.90%
EPRX - IVEVF
28%
Poorly correlated
-0.90%
ATHE - IVEVF
25%
Poorly correlated
+15.32%
IDRSF - IVEVF
20%
Poorly correlated
N/A
More